Literature DB >> 3755433

Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver.

C T Roberts, A L Brown, D E Graham, S Seelig, S Berry, K H Gabbay, M M Rechler.   

Abstract

Insulin-like growth factor I (IGF-I) is a mitogenic polypeptide present in the plasma of man and rat that is thought to mediate the actions of pituitary growth hormone on cartilage to promote skeletal elongation. In the rat, plasma levels of IGF-I show both developmental and hormonal regulation: levels are low at birth, increase with age, and are decreased in growth hormone-deficient adult animals. The present study demonstrates that these changes in plasma IGF-I reflect the abundance of IGF-I RNA in rat liver. A human IGF-I cDNA probe hybridized to multiple RNA species in adult rat liver with sizes 8.6, 4.6, 3.2, 2.1, and 1.0-1.4 kilobases. These RNA species were decreased by greater than 80% in neonatal (2- and 12-day-old) rat liver and by greater than 90% in liver from adult rats made growth hormone-deficient by hypophysectomy. Treatment of hypophysectomized rats with growth hormone increased the abundance of all species of IGF-I RNA. These results suggest that growth hormone regulates the expression of its physiological mediator by altering the synthesis, stability, or both of IGF-I RNA in rat liver.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755433

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Molecular biology of the insulin-like growth factors. Relevance to nervous system function.

Authors:  J E Hepler; P K Lund
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

2.  Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease.

Authors:  Miguel Agustin Contreras; William Louis Ries; Srinivasan Shanmugarajan; Gonzalo Arboleda; Inderjit Singh; Avtar Kaur Singh
Journal:  Biochim Biophys Acta       Date:  2010-05-02

3.  Translational mixed-effects PKPD modelling of recombinant human growth hormone - from hypophysectomized rat to patients.

Authors:  A Thorsted; P Thygesen; H Agersø; T Laursen; M Kreilgaard
Journal:  Br J Pharmacol       Date:  2016-04-21       Impact factor: 8.739

4.  Body size from birth through adolescence in relation to risk of benign breast disease in young women.

Authors:  Catherine S Berkey; Bernard Rosner; Rulla M Tamimi; Walter C Willett; Martha Hickey; Adetunji Toriola; A Lindsay Frazier; Graham A Colditz
Journal:  Breast Cancer Res Treat       Date:  2017-01-06       Impact factor: 4.872

5.  Effects of postweaning calorie restriction on accelerated growth and adiponectin in nutritionally programmed microswine offspring.

Authors:  Elizabeth A DuPriest; Baoyu Lin; Philipp Kupfer; Kaiu Sekiguchi; Amruta Bhusari; Alexandra Quackenbush; Almir Celebic; Terry K Morgan; Jonathan Q Purnell; Susan P Bagby
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-20       Impact factor: 3.619

6.  Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex.

Authors:  M M Niblock; J K Brunso-Bechtold; D R Riddle
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 7.  Tamoxifen reduces serum insulin-like growth factor I (IGF-I).

Authors:  M N Pollak; H T Huynh; S P Lefebvre
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period.

Authors:  Julien Auffret; Michael Freemark; Nadège Carré; Yves Mathieu; Cécile Tourrel-Cuzin; Marc Lombès; Jamileh Movassat; Nadine Binart
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-24       Impact factor: 4.310

9.  Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I.

Authors:  W L Lowe; C T Roberts; S R Lasky; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.